Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Arq Gastroenterol ; 60(3): 330-338, 2023.
Article in English | MEDLINE | ID: mdl-37792762

ABSTRACT

•The outcomes of CDI were evaluated in 65 patients with CDI in a Brazilian tertiary hospital. •Lack of clinical improvement after treatment and the severity score (ATLAS) increased the risk of death. •The use of multiple antimicrobial agents was associated with longer hospital stays. •Patients with high Charlson comorbidity index (>7) were more likely to recur. Background - Clostridioides difficile infection (CDI) is a potentially severe disease that can present with refractoriness, recurrence, and evolution to death. In Brazil, the epidemiology of CDI seems to differ from that of the United States and most European countries, with only one ribotype (RT) 027-related case and a high prevalence of RT106. Objective - The aim of this study was to evaluate the outcomes of CDI and its possible association with ribotypes at a university hospital in Brazil. Methods - A total of 65 patients with CDI were included and stool samples were submitted to A/B toxin detection and toxigenic culture, and toxigenic isolates (n=44) were also PCR ribotyped. Results - Patients' median age was 59 (20-87) years and there were 16 (24.6%) deaths. The median Charlson comorbidity index (CCI) was 4 (0-15) and 16.9% of the patients had CCI ≥8. The ATLAS score and non-improvement of diarrhea were related to higher mortality. A longer length of hospitalization was related to the enteral nutrition and use of multiple antibiotics. The period between CDI diagnosis and hospital discharge was longer in those who received new antibiotics after diagnosis, multiple antibiotics, and required intensive care treatment. Recurrence was associated with CCI >7. Twenty ribotypes were identified and RT106 was the most frequently detected strain (43.2%). No relationship was observed between the ribotypes and outcomes. CDI was present in patients with more comorbidities. Conclusion - Risk factors for higher mortality, longer hospital stay and recurrence were identified. A diversity of ribotypes was observed and C. difficile strains were not related to the outcomes.


Subject(s)
Clostridioides difficile , Clostridium Infections , Humans , Middle Aged , Clostridioides , Tertiary Care Centers , Brazil/epidemiology , Clostridium Infections/epidemiology , Anti-Bacterial Agents/therapeutic use , Clostridium
2.
Arq. gastroenterol ; 60(3): 330-338, July-Sept. 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1513704

ABSTRACT

ABSTRACT Background: Clostridioides difficile infection (CDI) is a potentially severe disease that can present with refractoriness, recurrence, and evolution to death. In Brazil, the epidemiology of CDI seems to differ from that of the United States and most European countries, with only one ribotype (RT) 027-related case and a high prevalence of RT106. Objective: The aim of this study was to evaluate the outcomes of CDI and its possible association with ribotypes at a university hospital in Brazil. Methods: A total of 65 patients with CDI were included and stool samples were submitted to A/B toxin detection and toxigenic culture, and toxigenic isolates (n=44) were also PCR ribotyped. Results: Patients' median age was 59 (20-87) years and there were 16 (24.6%) deaths. The median Charlson comorbidity index (CCI) was 4 (0-15) and 16.9% of the patients had CCI ≥8. The ATLAS score and non-improvement of diarrhea were related to higher mortality. A longer length of hospitalization was related to the enteral nutrition and use of multiple antibiotics. The period between CDI diagnosis and hospital discharge was longer in those who received new antibiotics after diagnosis, multiple antibiotics, and required intensive care treatment. Recurrence was associated with CCI >7. Twenty ribotypes were identified and RT106 was the most frequently detected strain (43.2%). No relationship was observed between the ribotypes and outcomes. CDI was present in patients with more comorbidities. Conclusion: Risk factors for higher mortality, longer hospital stay and recurrence were identified. A diversity of ribotypes was observed and C. difficile strains were not related to the outcomes.


RESUMO Contexto: A infecção pelo Clostridioides difficile (ICD) é uma doença potencialmente grave que pode se apresentar com refratariedade, recidiva e evoluir para óbito. No Brasil, a epidemiologia da ICD parece diferir da dos Estados Unidos e da maioria dos países europeus, com apenas um caso relacionado ao ribotipo (RT) 027 e alta prevalência do RT106. Objetivo: Avaliar os desfechos da ICD e sua possível associação com ribotipos em um hospital universitário do Brasil. Métodos: Um total de 65 pacientes com ICD foram incluídos e amostras de fezes foram submetidas à detecção de toxina A/B e cultura toxigênica e as cepas toxigênicas isoladas (n=44) também foram ribotipadas por PCR. Resultados: A idade mediana dos pacientes foi de 59 (20-87) anos e houve 16 (24,6%) óbitos. A mediana do índice de comorbidade de Charlson (ICC) foi de 4 (0-15) e 16,9% dos pacientes apresentaram ICC ≥8. O escore ATLAS e a não melhora da diarreia foram relacionados a maior mortalidade. Maior tempo de internação esteve relacionado à nutrição enteral e ao uso de múltiplos antibióticos. O período entre o diagnóstico de ICD e a alta hospitalar foi maior naqueles que receberam novos antibióticos após o diagnóstico, múltiplos antibióticos e necessitaram de tratamento intensivo. A recorrência foi associada com ICC >7. Vinte ribotipos foram identificados e o RT106 foi a cepa mais frequentemente detectada (43,2%). Não foi observada relação entre os ribotipos e os desfechos. ICD esteve presente em pacientes com mais comorbidades. Conclusão: Foram identificados fatores de risco para maior mortalidade, maior tempo de internação e recorrência. Uma diversidade de ribotipos foi observada e cepas de C. difficile não foram relacionadas aos desfechos.

3.
Inflammation ; 45(2): 544-553, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34618276

ABSTRACT

Variceal bleeding is a serious complication in cirrhotic patients and is related to increased expression of inflammatory mediators that accentuate circulatory dysfunction. The study aims to evaluate the performance of high mobility protein group 1 (HMG1) and interleukin-6 (IL-6) as predictors of acute kidney injury (AKI), infection and death in these patients. Fifty patients who were diagnosed with advanced chronic liver disease with variceal bleeding were included. The mean age was 52.8 ± 10.8 years, and 33 (66%) were male. Twenty-one (42%) patients were classified as Child-Pugh C, 21 (42%) Child-Pugh B and 8 (16%) Child-Pugh A. The mean HMG1 serum level was 2872.36 pg/mL ± 2491.94, and the median IL-6 serum level was 47.26 pg/mL (0-1102.4). In AKI, the serum level of HMG1 that performed best on the ROC curve was 3317.9 pg/mL. The IL-6 serum level was not associated with AKI. HMG1 and IL-6 cut-off values that better predicted infection were 3317.9 pg/mL and 72.9 pg/mL, and for mortality, the values were 2668 pg/mL and 84.5 pg/mL, respectively. In multivariate analysis, the variables that were associated with AKI and infection outcomes were model for end-stage liver disease and HMG1. Infections were related to the risk of death. Clinical and laboratory variables related to the outcomes were identified. Serum levels of HMG1 were associated with AKI and infection and had good performance in the ROC curve. IL-6 levels were not maintained in logistic regression outcomes but had good performance in infection and death outcomes. Such data will be useful for comparisons and possible future validations.


Subject(s)
End Stage Liver Disease , Esophageal and Gastric Varices , Liver Diseases , Adult , End Stage Liver Disease/complications , Esophageal and Gastric Varices/complications , Esophageal and Gastric Varices/diagnosis , Female , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/etiology , Humans , Interleukin-6 , Liver Cirrhosis/complications , Liver Diseases/complications , Male , Middle Aged , Prognosis , Severity of Illness Index
4.
Mediators Inflamm ; 2020: 2867241, 2020.
Article in English | MEDLINE | ID: mdl-33061824

ABSTRACT

BACKGROUND: Acute kidney injury (AKI) affects from 20% to 50% of cirrhotic patients, and the one-month mortality rate is 60%. The main cause of AKI is bacterial infection, which worsens circulatory dysfunction through the release of HMGB1 and IL-6. OBJECTIVES: To evaluate HMGB1 and IL-6 as biomarkers of morbidity/mortality. METHODS: Prospective, observational study of 25 hospitalised cirrhotic patients with AKI. Clinical and laboratory data were collected at the time of diagnosis of AKI, including serum HMGB1 and IL-6. RESULTS: The mean age was 55 years; 70% were male. Infections accounted for 13 cases. The 30-day and three-month mortality rates were 17.4% and 30.4%, respectively. HMGB1 levels were lower in survivors than in nonsurvivors at 30 days (1174.2 pg/mL versus 3338.5 pg/mL, p = 0.035), but not at three months (1540 pg/mL versus 2352 pg/mL, p = 0.243). Serum IL-6 levels were 43.3 pg/mL versus 153.3 pg/mL (p = 0.061) at 30 days and 35.8 pg/mL versus 87.9 pg/mL (p = 0.071) at three months, respectively. The area under the ROC curve for HMGB1 was 0.842 and 0.657, and that for IL-6 was 0.803 and 0.743 for discriminating nonsurvivors at 30 days and three months, respectively. In multivariate analysis, no biomarker was independently associated with mortality. CONCLUSION: HMGB1 levels were associated with decreased survival in cirrhotics. Larger studies are needed to confirm our results.


Subject(s)
Acute Kidney Injury/blood , Biomarkers/blood , HMGB1 Protein/blood , Interleukin-6/blood , Liver Cirrhosis/blood , Aged , Female , Humans , Male , Middle Aged , Multivariate Analysis
5.
Can J Gastroenterol Hepatol ; 2019: 6567850, 2019.
Article in English | MEDLINE | ID: mdl-30941330

ABSTRACT

Background: Acute kidney injury occurs in approximately 20% of hospitalized cirrhotic patients. Mortality is estimated at 60% within a month and 65% within a year. Aims: To evaluate survival in 30 days and in 3 months of cirrhotic patients hospitalized with acute kidney injury, identifying factors associated with mortality. Methods: 52 patients with cirrhosis admitted to an academic tertiary center who presented acute kidney injury according to the International Club of Ascites criteria were evaluated. Clinical and laboratory data was collected at diagnosis between 2011 and 2015. Results: Average age was 54.6 (±10.7) years and 69.2% were male. The average MELD, MELD-Na, and Child-Pugh scores were 21.9 (±7.0), 24.5 (±6.7), and 10.1 (±2.2), respectively. Thirty patients (57.7%) were in acute kidney injury stage 1, 16 (30.8%) in stage 2, and six (11.6%) in stage 3. Mortality was 28.6% in 30 days and 44.9% in three months. In multivariate analysis, variables that were associated independently to mortality were lack of response to expansion treatment and Child-Pugh score. Mortality was 93.3% in three months among nonresponders compared to 28.6% among those who responded to volume expansion (p<0.0001). Conclusion: Acute kidney injury in cirrhosis has dire prognosis, particularly in patients with advanced cirrhosis and in nonresponders to volume expansion.


Subject(s)
Acute Kidney Injury/etiology , Hospitalization , Liver Cirrhosis/complications , Acute Kidney Injury/epidemiology , Acute Kidney Injury/mortality , Adult , Aged , Female , Humans , Liver Cirrhosis/mortality , Liver Cirrhosis/therapy , Male , Middle Aged , Multivariate Analysis , Prognosis , Prospective Studies , Survival Rate , Time Factors
6.
J. bras. med ; 103(2)jan - 2016.
Article in Portuguese | LILACS | ID: lil-774684

ABSTRACT

Os autores relatam um caso de mesotelioma pleural benigno. São abordados aspectos histológicos, etiopatogênicos, genéticos, epidemiológicos e clínicos, bem como a casuística estudada, a terapêutica instituída e o segmento obtido. Abordam os critérios para o diagnóstico, resultante da somação de vários fatores, dando ênfase ao quadro clínico compatível, confirmação histopatológica, imuno-histopatológicos compatíveis com resposta positiva clínico-radiográfica e eficaz após a cirurgia proposta.


Cases of benign mesothelioma of the pleura are reported by authors. Histological, etiopathogenic, genetic, epidemiological and clinical aspects are approached as well the casuistry that was studied, established therapy and the acquired segment. It approaches the criteria for diagnosis resulted from many factors emphasizing compatible clinical condition, histopathological confirmation, compatible immuno-histopathology, effective and positive clinical radiography answer after the proposed surgery.


Subject(s)
Humans , Solitary Fibrous Tumor, Pleural/surgery , Solitary Fibrous Tumor, Pleural/diagnosis , Solitary Fibrous Tumor, Pleural/pathology , Mesothelioma , Biopsy, Needle/instrumentation , Thoracotomy/methods
7.
J. bras. med ; 102(6)dez. 2014. ilus, tab, ilus
Article in Portuguese | LILACS | ID: lil-737126

ABSTRACT

A colonização intracavitária pulmonar aspergilar (CIPA) é caracterizada pela presença de massa miceliana de crescimento endocavitário. O agente mais frequente é o Aspergillus fumigatus, e a lesão cavitária é geralmente sequela de tuberculose e curada com história de hemoptise de repetição e baciloscopia negativa. Os autores analisaram retrospectivamente 190 casos de CIPA, entre abril de 1978 e março de 2008, no Serviço de Arquivo Médico do Hospital Universitário Lauro Wanderley e no Complexo Hospitalar Clementino Fraga, enfatizando a incidência, forma de apresentação clínica, enfermidades associadas, métodos, diagnósticos e conduta terapêutica.


The colonized intrapulmonary aspergilloma (CIPA) is characterized by the mass fungal in a existing pulmonary cavity, where the most commonly agent is the Aspergillus fumigatus. The pulmonary cavity is often result cured pulmonary tuberculosis with hemoptisis repletion history and bacilloscopy negative. The authors analyzed retrospectively 190 cases of CIPA from April 1978 to March 2008 in the University Hospital Lauro Wanderley and Hospital Complex Clementino Fraga emphasizing the incidence, clinical evolution, illness association, diagnosis method and treatment.


Subject(s)
Humans , Pulmonary Aspergillosis/diagnosis , Lung Diseases, Fungal/diagnosis , Amphotericin B/therapeutic use , Itraconazole/therapeutic use , Pulmonary Aspergillosis/surgery , Lung Diseases, Fungal/surgery
8.
J. bras. med ; 101(6)nov.-dez. 2013. ilus
Article in Portuguese | LILACS | ID: lil-712204

ABSTRACT

As dificuldades diagnósticas entre mesotelioma pleural e adenocarcinoma metastático na pleura exigem estudo amplo. Os autores ilustram um caso clínico cujo diagnóstico só foi estabelecido após realização de toracotomia, com retirada de material para análise imuno-histoquímica. A diferenciação diagnóstica é de fundamental importância, uma vez que envolvem conduta terapêutica e prognóstico distintos. O estudo adequado deve utilizar material obtido através de toracoscopia ou toracotomia e empregar coloração imuno-histoquímica, estudos com anticorpos monoclonais, microscopia eletrônica e pesquisa de marcadores tumorais.


The diagnosis difficulties distinguishing mesothelioma from pleural metastatic adenocarcinoma request wide study. The authors illustrate a clinical case whose diagnosis was only established after thoracotomy removing material for immune-histochemical analysis. The diagnosis differentiating is very important, because involves distinct treatment and prognosis. The appropriate study should use material obtained through thoracoscopy or thoracotomy and submitted to immune-histochemical coloration, studies with monoclonal antibodies, electronic microscopy and research of tumor makers.


Subject(s)
Humans , Pleural Neoplasms/diagnosis , Mesothelioma/diagnosis , Immunohistochemistry , Thoracotomy/instrumentation , Microscopy, Electron/instrumentation , Antibodies, Monoclonal/immunology
9.
Rev. Col. Bras. Cir ; 28(1): 68-70, jan.-fev. 2001. ilus
Article in Portuguese | LILACS | ID: lil-513503

ABSTRACT

Traumatic diaphragmatic hernia is defined as a laceration of the diaphragm with an abdominal viscera herniation into the thorax. It is usually asymptomatic, with the exception of the cases with obstruction, strangulation, necrosis or perforation of the herniaded viscera. It is classified as acute, latent or chronic, in accordance with the evolutive period. At the latent phase, symptoms are indefinite and the radiological signals, which are suggestive of thoracic affections, are frequent and can induce a diagnosis error, leading to inadequate treatment.This article presents a case of chronic traumatic diaphragmatic hernia which was complicated by a gastricpleuralcutaneous fistula, due to an inadequate thoracic drainage. Considering that this is a chronic affection with an unquestionable surgical indication, due to the complications risk, it is essential to have a detailed diagnostic investigation, which aims at both avoiding an intempestive or inadequate therapeutics behaviour and reducing the affection morbimortality. Recently, the videolaparoscopic approach has proved to be more precise when compared to the other diagnostic methods, by direct visualization of the diaphragmatic laceration, allowing its correction by an immediate suture.

11.
J. bras. med ; 67(5/6): 45-57, nov.-dez. 1994. ilus
Article in Portuguese | LILACS | ID: lil-164019

ABSTRACT

Os autores apresentam seis casos de "tumor evanescente de pulmao"(TEP), diagnosticados em parâmetros clínico-radiológicos, de 1988 a 1993, no Hospital Universitário Lauro Wanderley - UFPB, simulando nódulos pulmonares neoplásicos e que apresentam resposta favorável à conduta instituída para insuficiência cardíaca. Ilustram o tema em pauta com imagens de radiologia simples, tomografia computadorizada, cintilografia e ecocardiografia, enfatizando os aspectos pulmonares exuberantes, e apresentam revisao bibliográfica acerca do assunto.


Subject(s)
Humans , Male , Adult , Middle Aged , Cardiac Output, Low/complications , Lung Diseases/diagnosis , Pleural Effusion/diagnosis , Ventricular Dysfunction, Left/diagnosis , Lung Diseases/therapy , Pleural Effusion/therapy , Lung , Radiography, Thoracic , Tomography, X-Ray Computed
12.
J. bras. med ; 64(6): 191-2, 194-6, 198-200, jul. 1993. ilus, tab
Article in Portuguese | LILACS | ID: lil-182679

ABSTRACT

Os autores apresentam 10 casos de bola fúngica ocorridos no Hospital Universitário Lauro Wanderley (HULW) no período de 1985 a 1992, acrescidos de revisao bibliográfica sobre o assunto. Os 10 pacientes apresentavam antecedentes de tuberculose pulmonar e foram tratados por um período mínimo de seis meses com fármacos tuberculostáticos, corretamente administrados. Os enfermos revelaram sintomas hemorrágicos de pequena intensidade, sob a forma de surtos repetidos de hemopotise. A localizaçao da bola fúngica foi sempre no lobo superior direito do pulmao e a terapêutica, ressecçao cirúrgica (lobectomia em todos os pacientes). Após o ato cirúrgico foi administrada, em todos os casos, uma associaçao terapêutica à base de sulfametoxazol-trimetoprina durante período nunca inferior a seis meses consecutivos. Os autores ilustram, em maiores detalhes, um dos 10 casos estudados.


Subject(s)
Humans , Male , Middle Aged , Aspergillosis/diagnosis , Lung Diseases, Fungal/diagnosis , Aspergillosis/surgery , Pneumonectomy , Lung Diseases, Fungal/surgery
13.
CCS ; 12(1): 24-32, jan. 1990-jun. 1993. ilus
Article in Portuguese | LILACS | ID: lil-168426

ABSTRACT

Os autores, baseados em revisao bibliográfica e nas suas experiências, fazem algumas explanaçoes sobre o empiema pleural, seu curso progressivo e a sua infectologia, desde o seu quadro inicial à sua cronificaçao. Eles enfatizam as suas seqüelas fibróticas, cujas respostas às terapêuticas vao se tornando mais complexas à medida que se prolonga a sua resoluçao, a partir da simples drenagem sub-aquática, no momento do esvaziamento, à rude toracoplastia quando se deseja oblitear uma cavidade residual. Eles, ainda, adicionam fotografias de radiografias e de pacientes por eles tratados com técnicas cirúrgicas difundidas pela literatura, na idéia de melhor ilustrar o presente trabalho.


Subject(s)
Humans , Empyema, Pleural/diagnosis , Empyema, Pleural/etiology , Empyema, Pleural/surgery , Pneumonectomy/adverse effects , Postoperative Complications
14.
Unidade méd ; 2(15): 21-6, out.-dez. 1990. ilus
Article in Portuguese | LILACS | ID: lil-91842

ABSTRACT

O carcinoma avenocelular de pulmäo tem certas particularidades que o difere das demais neoplasias pulmonares. Os autores, tendo acompanhado e operado câncer de pulmäo por mais de 10 anos, após revisäo bibliográfica, fazem algumas reflexöes sobre as exclusividades desse tumor e as impressöes gerais da sua remoçäo cirúrgica como mais uma forma, dentro da multiplicidade terapêutica. Embora reconheçam a crirugia como repleta de controvérsias e que o tumor tenha sido, até pouquíssimos tempos atrás, um dos critérios de inoperabilidade, vislumbram a conduta como uma luz no final do túnel na resoluçäo definitiva de täo agressivo carcinoma


Subject(s)
Humans , Carcinoma, Small Cell/surgery , Lung Neoplasms/surgery , Carcinoma, Small Cell/pathology , Lung Neoplasms/pathology , Prognosis
15.
CCS ; 9(1): 21-7, jan.-mar. 1987. tab, ilus
Article in Portuguese | LILACS, Sec. Est. Saúde SP | ID: lil-53398

ABSTRACT

Apresentamos 10 casos de Aspergiloma Pulmonar Intracavitário (API), acrescidos de uma revisäo bibliográfica sobre o assunto. Todos os pacientes tiveram passado de tuberculose pulmonar e foram tratados por um período mínimo de 6 meses com drogas antituberculosas. Os 10 pacientes acusaram sintomatologia hemorrágica, sendo 4 sob a forma de hemoptise de repetiçäo e 6 sob a forma de hemoptoicos. As localizaçöes foram de lobos superiores, mostrando uma predominância para o lobo superior direito. A terapêutica empregada foi a resseccionalista (lobectomia) em todos os casos. Em todos os operados fez-se cobertura terapêutica com Sulfadiazina, por um período nunca inferior a 6 meses consecutivos. Ilustramos o tema em pauta com a apresentaçäo de um caso clínico-rádio-anatomopatológico, com o quadro pulmonar dominando toda a cena


Subject(s)
Adult , Humans , Male , Aspergillosis/etiology , Lung Diseases, Fungal/complications , Pyrazinamide/therapeutic use , Aspergillosis/drug therapy , Aspergillosis , Rifampin/therapeutic use , Isoniazid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...